APE1/Ref-1 Role in Inflammation and Immune Response
Overview
Authors
Affiliations
Apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1) is a multifunctional enzyme that is essential for maintaining cellular homeostasis. APE1 is the major apurinic/apyrimidinic endonuclease in the base excision repair pathway and acts as a redox-dependent regulator of several transcription factors, including NF-κB, AP-1, HIF-1α, and STAT3. These functions render APE1 vital to regulating cell signaling, senescence, and inflammatory pathways. In addition to regulating cytokine and chemokine expression through activation of redox sensitive transcription factors, APE1 participates in other critical processes in the immune response, including production of reactive oxygen species and class switch recombination. Furthermore, through participation in active chromatin demethylation, the repair function of APE1 also regulates transcription of some genes, including cytokines such as TNFα. The multiple functions of APE1 make it an essential regulator of the pathogenesis of several diseases, including cancer and neurological disorders. Therefore, APE1 inhibitors have therapeutic potential. APE1 is highly expressed in the central nervous system (CNS) and participates in tissue homeostasis, and its roles in neurodegenerative and neuroinflammatory diseases have been elucidated. This review discusses known roles of APE1 in innate and adaptive immunity, especially in the CNS, recent evidence of a role in the extracellular environment, and the therapeutic potential of APE1 inhibitors in infectious/immune diseases.
Hypoxia-inducible factor and cellular senescence in pulmonary aging and disease.
Thapa R, Marianesan A, Rekha A, Ganesan S, Kumari M, Bhat A Biogerontology. 2025; 26(2):64.
PMID: 40011266 PMC: 11865175. DOI: 10.1007/s10522-025-10208-z.
Li L, Zhao Y, Ding Y, Guo L, Dai R, Chen A Sci Rep. 2025; 15(1):4106.
PMID: 39900709 PMC: 11790883. DOI: 10.1038/s41598-025-87182-6.
Serum proteome profiling of plateau acclimatization in men using Olink proteomics approach.
Pan J, Dong Y, Zou Z, Gu T, Chen L, Li K Physiol Rep. 2024; 12(24):e70091.
PMID: 39725655 PMC: 11671244. DOI: 10.14814/phy2.70091.
Grzeczka A, Graczyk S, Kordowitzki P Cells. 2024; 13(20.
PMID: 39451250 PMC: 11505706. DOI: 10.3390/cells13201732.
Yang L, Sun Z Mol Clin Oncol. 2024; 21(5):82.
PMID: 39301126 PMC: 11411593. DOI: 10.3892/mco.2024.2780.